Latest Revenue Growth News

Vitura Health reports sustained revenue and EBITDA growth in Q3 FY2025, driven by recent acquisitions and operational improvements, positioning the company well for FY2026.

PEXA Group’s third-quarter results align with expectations, driven by Australian growth and UK market headwinds. The company reaffirms its FY25 guidance while navigating ongoing business assessments and regulatory milestones.

Southern Cross Media Group rebuffs Sandon Capital’s attempt to remove four directors, backed by majority shareholders and buoyed by strong operational momentum.

IODM Limited has secured a new revenue share agreement with Converain targeting Japan’s growing international education market, marking its fourth such deal globally.

News Corporation reported a 3% revenue increase to $2.009 billion for Q3 2025, with net income attributable to stockholders tripling to $137 million. The company completed the strategic sale of Foxtel, marking a significant shift in its operations.

FleetPartners Group Limited reported a 2.6% revenue increase to $377 million for the half-year ended March 2025, while net profit after tax declined 5.3% to $34.5 million, reflecting operational headwinds from a major system upgrade.

Orthocell has rapidly expanded its US distributor network for Remplir™, surpassing its target ahead of schedule and positioning itself for imminent sales in the $1.6 billion nerve repair market.

News Corporation reported a modest 1% revenue increase to $2.01 billion and a striking 67% jump in net income for Q3 Fiscal 2025, driven by digital subscription growth and strategic asset realignment including the Foxtel sale.

AVITA Medical reported a strong first quarter with revenues up 67% to $18.5 million, driven by expanded commercial sales and new product introductions. Despite a narrower net loss, the company faces ongoing challenges from revenue covenants and macroeconomic pressures.

AVITA Medical reveals a bold expansion plan targeting a $3.5 billion U.S. acute wound care market by 2025, driven by a multi-product portfolio and sustained revenue growth.

AVITA Medical reported a robust 67% increase in first quarter 2025 revenue, driven by new product launches and a strategic commercial overhaul, while reaffirming its full-year growth and profitability targets.

REA Group has posted robust growth in its Q3 results, driven by strong buyer demand and strategic product enhancements across its digital real estate platforms.